Cardiol Therapeutics Inc. (CRDL.TO)
CAD 1.96
(0.51%)
CAD 1.96
(0.51%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -248.35 Thousand CAD | -12.94% |
| 2022 | -219.9 Thousand CAD | -379.21% |
| 2021 | 78.76 Thousand CAD | 134.31% |
| 2020 | -229.53 Thousand CAD | -52.44% |
| 2019 | -150.57 Thousand CAD | -64.57% |
| 2018 | -91.49 Thousand CAD | -71.52% |
| 2017 | -53.34 Thousand CAD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | -61.9 Thousand CAD | -0.46% |
| 2024 Q1 | -61.62 Thousand CAD | 7.7% |
| 2023 Q4 | -66.76 Thousand CAD | -2.88% |
| 2023 FY | -248.35 Thousand CAD | -12.94% |
| 2023 Q3 | -64.89 Thousand CAD | -10.94% |
| 2023 Q2 | -58.49 Thousand CAD | -0.5% |
| 2023 Q1 | -58.2 Thousand CAD | -0.29% |
| 2022 Q2 | -53.77 Thousand CAD | -0.3% |
| 2022 Q1 | -53.62 Thousand CAD | 3.54% |
| 2022 FY | -219.9 Thousand CAD | -379.21% |
| 2022 Q4 | -58.03 Thousand CAD | -6.53% |
| 2022 Q3 | -54.47 Thousand CAD | -1.29% |
| 2021 Q1 | -54.62 Thousand CAD | 0.0% |
| 2021 Q2 | 78.76 Thousand CAD | 244.2% |
| 2021 Q3 | -55.58 Thousand CAD | -170.58% |
| 2021 Q4 | -55.59 Thousand CAD | -0.0% |
| 2021 FY | 78.76 Thousand CAD | 134.31% |
| 2020 FY | -229.53 Thousand CAD | -52.44% |
| 2020 Q4 | - CAD | 0.0% |
| 2020 Q3 | - CAD | 0.0% |
| 2020 Q2 | - CAD | 0.0% |
| 2020 Q1 | - CAD | 0.0% |
| 2019 Q1 | - CAD | 0.0% |
| 2019 FY | -150.57 Thousand CAD | -64.57% |
| 2019 Q2 | - CAD | 0.0% |
| 2019 Q4 | - CAD | 0.0% |
| 2019 Q3 | - CAD | 0.0% |
| 2018 Q4 | - CAD | 0.0% |
| 2018 Q1 | - CAD | 0.0% |
| 2018 FY | -91.49 Thousand CAD | -71.52% |
| 2018 Q2 | - CAD | 0.0% |
| 2018 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 FY | -53.34 Thousand CAD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Aurora Cannabis Inc. | 131.46 Million CAD | 100.189% |
| Avicanna Inc. | 6.65 Million CAD | 103.73% |
| Avant Brands Inc. | 12.43 Million CAD | 101.998% |
| Crescita Therapeutics Inc. | 10.36 Million CAD | 102.396% |
| Knight Therapeutics Inc. | 152.65 Million CAD | 100.163% |
| MediPharm Labs Corp. | 5.85 Million CAD | 104.242% |
| OrganiGram Holdings Inc. | 35.07 Million CAD | 100.708% |
| Canopy Growth Corporation | 80.88 Million CAD | 100.307% |
| Willow Biosciences Inc. | -659 Thousand CAD | 62.313% |
| Auxly Cannabis Group Inc. | 21.27 Million CAD | 101.167% |